Endoscopy
DOI: 10.1055/a-2463-1737
Original article

Association between colonoscopy and colorectal cancer occurrence and mortality in the older population: a population-based cohort study

Ji Young Lee
1   Health Screening and Promotion Center, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea (the Republic of)
,
Jae Myung Cha
2   Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)
,
Jin Young Yoon
2   Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)
,
Min Seob Kwak
2   Department of Internal Medicine, Kyung Hee University Hospital at Gang Dong, College of Medicine, Kyung Hee University, Seoul, Korea (the Republic of)
,
Hun Hee Lee
3   Big Data Center, Kyung Hee University Hospital at Gang Dong, Seoul, Korea (the Republic of)
› Author Affiliations
Supported by: Research Supporting Program of the Korean Association for the Study of Intestinal Diseases for 2021

Abstract

Background

We aimed to evaluate the association between colonoscopy and colorectal cancer (CRC) occurrence and related mortality in an older population.

Methods

This retrospective, nationwide, population-based cohort study used data of adults aged ≥40 years from the Health Insurance Review and Assessment Service database. After excluding colonoscopy within 6 months of CRC diagnosis during enrollment, CRC occurrence and related mortality were compared between colonoscopy and non-colonoscopy groups using a time-dependent Cox proportional hazard model. Subgroup analysis was conducted among four age groups: young, middle-aged, old, and very old.

Results

Among 748986 individuals followed for 9.64 (SD 0.99) years, the colonoscopy group had a 65% lower CRC occurrence (adjusted hazard ratio [HRa] 0.35, 95%CI 0.32–0.38) and 76% lower CRC-related mortality (HRa 0.24, 95%CI 0.18–0.31) after 5 years compared with the non-colonoscopy group. Colonoscopy was associated with the most significant reduction in CRC occurrence in the middle-aged group (HRa 0.32, 95%CI 0.29–0.35) and in CRC-related mortality in the young group (HRa 0.04, 95%CI 0.01–0.33); the very old group had the least reduction in both CRC occurrence and CRC-related mortality (HRa 0.44, 95%CI 0.33–0.59 and HRa 0.28, 95%CI 0.15–0.53, respectively).

Conclusion

We found a significant association between colonoscopy and reduction in CRC occurrence and CRC-related mortality in adults aged ≥40 years after 5 years of follow-up; however, these associations were weaker in the very old group. More research is needed on the association between colonoscopy and older age.

Supplementary Material



Publication History

Received: 19 March 2024

Accepted after revision: 06 November 2024

Accepted Manuscript online:
06 November 2024

Article published online:
10 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Doubeni CA, Corley DA, Quinn VP. et al. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut 2018; 67: 291-298
  • 2 Kahi CJ, Pohl H, Myers LJ. et al. Colonoscopy and colorectal cancer mortality in the Veterans Affairs health care system: a case-control study. Ann Intern Med 2018; 168: 481-488
  • 3 Manser CN, Bachmann LM, Brunner J. et al. Colonoscopy screening markedly reduces the occurrence of colon carcinomas and carcinoma-related death: a closed cohort study. Gastrointest Endosc 2012; 76: 110-117
  • 4 Nishihara R, Wu K, Lochhead P. et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013; 369: 1095-1105
  • 5 Sung JJ, Ng SC, Chan FK. et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 2015; 64: 121-132
  • 6 Davidson KW, Barry MJ. US Preventive Services Task Force. et al. Screening for colorectal cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2021; 325: 1965-1977
  • 7 Kim Y, Jun JK, Choi KS. et al. Overview of the National Cancer screening programme and the cancer screening status in Korea. Asian Pac J Cancer Prev 2011; 12: 725-730
  • 8 Cha JM, Kwak MS, Kim HS. et al. Real-world national colonoscopy volume in Korea: a nationwide population-based study over 12 years. Gut Liver 2020; 14: 338-346
  • 9 Suh M, Song S, Cho HN. et al. Trends in participation rates for the national cancer screening program in Korea, 2002–2012. Cancer Res Treat 2017; 49: 798-806
  • 10 Cha JM. Would you recommend screening colonoscopy for the very elderly?. Intest Res 2014; 12: 275-280
  • 11 Lieberman DA, Williams JL, Holub JL. et al. Colonoscopy utilization and outcomes 2000 to 2011. Gastrointest Endosc 2014; 80: 133-143 e3
  • 12 Cheol Seong S, Kim YY, Khang YH. et al. Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea. Int J Epidemiol 2017; 46: 799-800
  • 13 Hwang YJ, Kim N, Yun CY. et al. Validation of administrative big database for colorectal cancer searched by international classification of disease 10th codes in Korean: a retrospective big-cohort study. J Cancer Prev 2018; 23: 183-190
  • 14 Baxter NN, Warren JL, Barrett MJ. et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012; 30: 2664-2669
  • 15 Lim S, Marcus SM, Singh TP. et al. Bias due to sample selection in propensity score matching for a supportive housing program evaluation in New York City. PLoS One 2014; 9: e109112
  • 16 Quan H, Li B, Couris CM. et al. Updating and validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge abstracts using data from 6 countries. Am J Epidemiol 2011; 173: 676-682
  • 17 Fisher LD, Lin DY. Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 1999; 20: 145-157
  • 18 Zauber AG, Winawer SJ, O’Brien MJ. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012; 366: 687-696
  • 19 Muto T, Bussey HJ, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270
  • 20 García-Albéniz X, Hsu J, Bretthauer M. et al. Effectiveness of screening colonoscopy to prevent colorectal cancer among Medicare beneficiaries aged 70 to 79 years: a prospective observational study. Ann Intern Med 2017; 166: 18-26
  • 21 Ma W, Wang K, Nguyen LH. et al. Association of screening lower endoscopy with colorectal cancer incidence and mortality in adults older than 75 years. JAMA Oncol 2021; 7: 985-992
  • 22 Lin OS, Kozarek RA, Schembre DB. et al. Screening colonoscopy in very elderly patients: prevalence of neoplasia and estimated impact on life expectancy. JAMA 2006; 295: 2357-2365
  • 23 Day LW, Kwon A, Inadomi JM. et al. Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc 2011; 74: 885-896
  • 24 Gatto NM, Frucht H, Sundararajan V. et al. Risk of perforation after colonoscopy and sigmoidoscopy: a population-based study. J Natl Cancer Inst 2003; 95: 230-236
  • 25 Lee JA, Chang Y, Kim Y. et al. Colonoscopic screening and risk of all-cause and colorectal cancer mortality in young and older individuals. Cancer Res Treat 2023; 55: 618-625
  • 26 Jodal HC, Helsingen LM, Anderson JC. et al. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open 2019; 9: e032773
  • 27 Shaukat A, Mongin SJ, Geisser MS. et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106-1114
  • 28 Shaukat A, Kaalby L, Baatrup G. et al. Effects of screening compliance on long-term reductions in all-cause and colorectal cancer mortality. Clin Gastroenterol Hepatol 2021; 19: 967-975 e2
  • 29 Zheng S, Schrijvers JJA, Greuter MJW. et al. Effectiveness of colorectal cancer (CRC) screening on all-cause and CRC-specific mortality reduction: a systematic review and meta-analysis. Cancers (Basel) 2023; 15: 1948
  • 30 Yoon JY, Kwak MS, Kim HI. et al. Seasonal variations in the diagnosis of the top 10 cancers in Korea: a nationwide population-based study using a common data model. J Gastroenterol Hepatol 2021; 36: 3371-3380
  • 31 Berstad P, Løberg M, Larsen IK. et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 2015; 64: 1268-1276
  • 32 Larsen IK, Grotmol T, Almendingen K. et al. Impact of colorectal cancer screening on future lifestyle choices: a three-year randomized controlled trial. Clin Gastroenterol Hepatol 2007; 5: 477-483
  • 33 Carethers JM, Doubeni CA. Causes of socioeconomic disparities in colorectal cancer and intervention framework and strategies. Gastroenterology 2020; 158: 354-367
  • 34 Fowler H, Belot A, Ellis L. et al. Comorbidity prevalence among cancer patients: a population-based cohort study of four cancers. BMC Cancer 2020; 20: 2
  • 35 Yoon SJ, Kim EJ, Seo HJ. et al. The Association between Charlson Comorbidity Index and the medical care cost of cancer: a retrospective study. Biomed Res Int 2015; 2015: 259341